← Leaderboards
Daniel C. Javitt
New York University School Of Medicine
$42,318,725
Attributed
$49,586,826
Total exposure
24
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$64,255,653 · 26
By mechanism
R01$29,092,864 · 11
P50$14,936,493 · 4
U01$9,851,975 · 3
R37$4,184,077 · 1
RF1$2,338,855 · 1
R24$1,318,097 · 1
Top collaborators
- Antigona Martinez4 shared
- Pejman Sehatpour4 shared
- Jack Grinband3 shared
- Joshua Tolkien Kantrowitz3 shared
- Samuel A Neymotin3 shared
- Monica Noelle O'Connell3 shared
- Robert Milton Sears3 shared
- Christoph Juchem1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Glen M Doniger$36,663
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaNeurophysiologyFunctional DisorderImpaired CognitionBehavioralGenerationsBaseImpairmentSensoryAuditoryFutureResponseEvent-Related PotentialsStimulusGlutamatesBrainIndexingFunctional Magnetic Resonance ImagingVisualBrain RegionPatternN-MethylaspartateCognitionInvestigation
Grant awards (123)
Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic development$2,338,855
RF1 · FY2025 · MH · contact PI
Use of alpha-frequency deep transcranial interference stimulation (tIS) to understand and modify temporal dynamics of face emotion recognition and social/affective function.$937,152
U01 · FY2025 · MH · contact PI
A Schizophrenia Extension Study for the NKI Rockland Sample II project: An Open Resource of Multimodal Brain, Physiology & Behavior from a Community Lifespan Sample$820,625
R01 · FY2025 · MH · contact PI
Sensory contributions to third visual pathway dysfunction in schizophrenia: correlation and causation$778,548
R01 · FY2025 · MH · contact PI
Use of alpha-frequency deep transcranial interference stimulation (tIS) to understand and modify temporal dynamics of face emotion recognition and social/affective function.$1,045,140
U01 · FY2024 · MH · contact PI
Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic development$806,008
R01 · FY2024 · MH · contact PI
A Schizophrenia Extension Study for the NKI Rockland Sample II project: An Open Resource of Multimodal Brain, Physiology & Behavior from a Community Lifespan Sample$798,736
R01 · FY2024 · MH · contact PI
Neural Mechanisms of Reading Dysfunction in Schizophrenia$674,514
R01 · FY2024 · MH · contact PI
Neural Mechanisms of Reading Dysfunction in Schizophrenia$97,582
R01 · FY2024 · MH · contact PI
Neural Mechanisms of Reading Dysfunction in Schizophrenia$39,896
R01 · FY2024 · MH · contact PI
Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic development$819,484
R01 · FY2023 · MH · contact PI
Neural Mechanisms of Reading Dysfunction in Schizophrenia$678,490
R01 · FY2023 · MH · contact PI
Glutamatergic mechanisms of psychosis and target engagement$717,908
R01 · FY2022 · MH
Early Cortical Processing in Schizophrenia$713,492
R01 · FY2022 · MH · contact PI
Neural Mechanisms of Reading Dysfunction in Schizophrenia$680,545
R01 · FY2022 · MH · contact PI
Glutamatergic mechanisms of psychosis and target engagement$723,999
R01 · FY2021 · MH
Early Cortical Processing in Schizophrenia$721,727
R01 · FY2021 · MH · contact PI
Neural Mechanisms of Reading Dysfunction in Schizophrenia$688,683
R01 · FY2021 · MH · contact PI
Early Cortical Processing in Schizophrenia$40,428
R01 · FY2021 · MH · contact PI
Early Cortical Processing in Schizophrenia$815,749
R01 · FY2020 · MH · contact PI
Glutamatergic mechanisms of psychosis and target engagement$757,837
R01 · FY2020 · MH
Temporal Dynamics of Neurophysiological Patterns as Treatment Targets in Scz$743,052
R01 · FY2020 · MH · contact PI
Neural Mechanisms of Reading Dysfunction in Schizophrenia$718,910
R01 · FY2020 · MH · contact PI
Early Cortical Processing in Schizophrenia$45,279
R01 · FY2020 · MH · contact PI
Early Cortical Processing in Schizophrenia$889,414
R01 · FY2019 · MH · contact PI
Temporal Dynamics of Neurophysiological Patterns as Treatment Targets in Scz$755,066
R01 · FY2019 · MH · contact PI
Temporal Dynamics of Neurophysiological Patterns as Treatment Targets in Scz$782,036
R01 · FY2018 · MH · contact PI
Early Cortical Processing in Schizophrenia$588,720
R01 · FY2018 · MH · contact PI
Early Cortical Processing in Schizophrenia$696,148
R01 · FY2017 · MH · contact PI
Temporal dynamics of neurophysiological patterns as treatment targets in Sz$658,732
R01 · FY2017 · MH · contact PI
tDCS Augmentation of Cognitive Remediation in Schizophrenia$226,450
R33 · FY2017 · MH
Temporal dynamics of neurophysiological patterns as treatment targets in Sz$804,491
R01 · FY2016 · MH · contact PI
Early Cortical Processing in Schizophrenia$696,148
R01 · FY2016 · MH · contact PI
tDCS Augmentation of Cognitive Remediation in Schizophrenia$280,000
R33 · FY2016 · MH · contact PI
Early Cortical Processing in Schizophrenia$827,111
R01 · FY2015 · MH · contact PI
tDCS Augmentation of Cognitive Remediation in Schizophrenia$280,000
R33 · FY2015 · MH · contact PI
Early Cortical Processing in Schizophrenia$720,338
R01 · FY2014 · MH · contact PI
tDCS Augmentation of Cognitive Remediation in Schizophrenia$252,061
R21 · FY2014 · MH · contact PI
Early Cortical Processing in Schizophrenia$108,675
R01 · FY2014 · MH · contact PI
The Conte Center for Schizophrenia Research$1,917,837
P50 · FY2013 · MH · contact PI
Early Cortical Processing in Schizophrenia$681,569
R01 · FY2013 · MH · contact PI
Administrative$329,283
P50 · FY2013 · MH · contact PI
tDCS Augmentation of Cognitive Remediation in Schizophrenia$263,160
R21 · FY2013 · MH · contact PI
Multimodal assessment of sensory processing dysfunction in schizophrenia$207,603
P50 · FY2013 · MH · contact PI
The Conte Center for Schizophrenia Research$2,029,359
P50 · FY2012 · MH · contact PI
Early Cortical Processing In Schizophrenia$429,658
R37 · FY2012 · MH · contact PI
Administrative$426,096
P50 · FY2012 · MH · contact PI
Multimodal assessment of sensory processing dysfunction in schizophrenia$235,389
P50 · FY2012 · MH · contact PI
The Conte Center for Schizophrenia Research$2,060,611
P50 · FY2011 · MH · contact PI
Early Cortical Processing In Schizophrenia$431,176
R37 · FY2011 · MH · contact PI
Administrative$380,890
P50 · FY2011 · MH · contact PI
Multimodal assessment of sensory processing dysfunction in schizophrenia$218,382
P50 · FY2011 · MH · contact PI
The Conte Center for Schizophrenia Research$2,095,143
P50 · FY2010 · MH · contact PI
Sensory Processing Dysfunction in Neuropsychiatric Illness$443,445
R24 · FY2010 · MH · contact PI
Early Cortical Processing In Schizophrenia$437,104
R37 · FY2010 · MH · contact PI
Administrative$370,210
P50 · FY2010 · MH · contact PI
The Conte Center for Schizophrenia Research$357,647
P50 · FY2010 · MH · contact PI
Phencyclidine Abuse & Psychosis: Biomedical Mechanisms$317,926
R01 · FY2010 · DA · contact PI
Early Cortical Processing In Schizophrenia$236,998
R37 · FY2010 · MH · contact PI
Multimodal assessment of sensory processing dysfunction in schizophrenia$213,437
P50 · FY2010 · MH · contact PI
The Conte Center for Schizophrenia Research$134,505
P50 · FY2010 · MH · contact PI
The Conte Center for Schizophrenia Research$2,147,398
P50 · FY2009 · MH · contact PI
PK/PD, DOSE FINDING AND ADJUNCTIVE TREATMENT STUDIES$844,187
U01 · FY2009 · MH · contact PI
D-Serine Treatment of Schizophrenia$844,187
U01 · FY2009 · MH · contact PI
Sensory Processing Dysfunction in Neuropsychiatric Illness$442,976
R24 · FY2009 · MH · contact PI
Early Cortical Processing In Schizophrenia$432,437
R37 · FY2009 · MH · contact PI
Administrative$407,208
P50 · FY2009 · MH · contact PI
Phencyclidine Abuse & Psychosis: Biomedical Mechanisms$318,206
R01 · FY2009 · DA · contact PI
Multimodal assessment of sensory processing dysfunction in schizophrenia$229,208
P50 · FY2009 · MH · contact PI
Early Cortical Processing In Schizophrenia$59,839
R37 · FY2009 · MH · contact PI
D-Serine Treatment of Schizophrenia$829,216
U01 · FY2008 · MH · contact PI
PK/PD, DOSE FINDING AND ADJUNCTIVE TREATMENT STUDIES$829,216
U01 · FY2008 · MH · contact PI
Methods for Sensory Assessment in Schizophrenia$515,505
R01 · FY2008 · MH · contact PI
Early Cortical Processing In Schizophrenia$453,043
R37 · FY2008 · MH · contact PI
Sensory Processing Dysfunction in Neuropsychiatric Illness$431,676
R24 · FY2008 · MH · contact PI
Phencyclidine Abuse & Psychosis: Biomedical Mechanisms$315,360
R01 · FY2008 · DA · contact PI
DOPAMINE IN A PRIMATE MODEL OF GLUTAMATE HYPOFUNCTION$184,059
P50 · FY2008 · MH · contact PI
D-Serine Treatment of Schizophrenia$825,031
U01 · FY2007 · MH · contact PI
PK/PD, DOSE FINDING AND ADJUNCTIVE TREATMENT STUDIES$825,031
U01 · FY2007 · MH · contact PI
Early Cortical Processing In Schizophrenia$327,488
R37 · FY2007 · MH · contact PI
Phencyclidine Abuse & Psychosis: Biomedical Mechanisms$318,719
R01 · FY2007 · DA · contact PI
DOPAMINE IN A PRIMATE MODEL OF GLUTAMATE HYPOFUNCTION$247,674
P50 · FY2007 · MH · contact PI
PK/PD, DOSE FINDING AND ADJUNCTIVE TREATMENT STUDIES$724,587
U01 · FY2006 · MH · contact PI
D-Serine Treatment of Schizophrenia$707,558
U01 · FY2006 · MH · contact PI
Early Cortical Processing In Schizophrenia$333,845
R37 · FY2006 · MH · contact PI
DOPAMINE IN A PRIMATE MODEL OF GLUTAMATE HYPOFUNCTION$254,350
P50 · FY2006 · MH · contact PI
Neurophysiological NMDA dysfunction in schizophrenia$125,388
K02 · FY2006 · MH · contact PI
PK/PD, DOSE FINDING AND ADJUNCTIVE TREATMENT STUDIES$720,335
U01 · FY2005 · MH
D-Serine Treatment of Schizophrenia$720,335
U01 · FY2005 · MH
Phencyclidine Abuse and Psychoses: Biomedical Mechanisms$340,616
R01 · FY2005 · DA
Early Cortical Processing In Schizophrenia$338,475
R37 · FY2005 · MH
MECHANISMS OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA$311,101
R01 · FY2005 · MH
DOPAMINE IN A PRIMATE MODEL OF GLUTAMATE HYPOFUNCTION$309,563
P50 · FY2005 · MH
Neurophysiological NMDA dysfunction in schizophrenia$125,388
K02 · FY2005 · MH
Phencyclidine Abuse and Psychoses: Biomedical Mechanisms$336,169
R01 · FY2004 · DA
Early Cortical Processing In Schizophrenia$335,169
R37 · FY2004 · MH
MECHANISMS OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA$307,865
R01 · FY2004 · MH
DOPAMINE IN A PRIMATE MODEL OF GLUTAMATE HYPOFUNCTION$180,641
P50 · FY2004 · MH
Neurophysiological NMDA dysfunction in schizophrenia$125,388
K02 · FY2004 · MH
TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENTS$402,948
R01 · FY2003 · MH
Early Cortical Processing In Schizophrenia$368,845
R37 · FY2003 · MH
Phencyclidine Abuse and Psychoses: Biomedical Mechanisms$331,893
R01 · FY2003 · DA
MECHANISMS OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA$304,724
R01 · FY2003 · MH
Neurophysiological NMDA dysfunction in schizophrenia$125,388
K02 · FY2003 · MH
NEUROANATOMIC BASIS OF COGNITIVE ERP DEFICIT IN SCHIZOPH$31,480
R03 · FY2003 · TW
TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENTS$391,215
R01 · FY2002 · MH
Phencyclidine Abuse and Psychoses: Biomedical Mechanisms$327,782
R01 · FY2002 · DA
EARLY CORTICAL PROCESSING IN SCHIZOPHRENIA$321,029
R01 · FY2002 · MH
MECHANISMS OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA$301,674
R01 · FY2002 · MH
High-Density ERP mapping &FMRI$295,720
S10 · FY2002 · RR
Neurophysiological NMDA dysfunction in schizophrenia$125,388
K02 · FY2002 · MH
EARLY CORTICAL PROCESSING IN SCHIZOPHRENIA$73,600
R01 · FY2002 · MH
NEUROANATOMIC BASIS OF COGNITIVE ERP DEFICIT IN SCHIZOPH$31,480
R03 · FY2002 · TW
EARLY CORTICAL PROCESSING IN SCHIZOPHRENIA$386,771
R01 · FY2001 · MH
TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENTS$379,816
R01 · FY2001 · MH
Phencyclidine Abuse and Psychoses: Biomedical Mechanisms$323,829
R01 · FY2001 · DA
MECHANISMS OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA$298,712
R01 · FY2001 · MH
NEUROPHYSIOLOGICAL NMDA DYSFUNCTION IN SCHIZOPHRENIA$107,463
K02 · FY2001 · MH
NEUROANATOMIC BASIS OF COGNITIVE ERP DEFICIT IN SCHIZOPH$31,480
R03 · FY2001 · TW
EARLY CORTICAL PROCESSING IN SCHIZOPHRENIA$443,055
R01 · FY2000 · MH
TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENTS$368,751
R01 · FY2000 · MH
PHENCYCLIDINE ABUSE AND PSYCHOSIS--BIOMEDICAL MECHANISMS$265,658
R01 · FY2000 · DA
NEUROPHYSIOLOGICAL NMDA DYSFUNCTION IN SCHIZOPHRENIA$107,058
K02 · FY2000 · MH